MicroRNA expression patterns and target prediction in multiple myeloma development and malignancy

Ivyna Pau Ni Bong,Zubaidah Zakaria,Ching Ching Ng,Puteri Baharuddin

doi:10.1007/s13258-017-0518-7

Ivyna Pau Ni Bong, Zubaidah Zakaria + Show 2 more

Open Access

https://doi.org/10.1007/s13258-017-0518-7

Copy DOI

Abstract

Epigenetic changes have emerged as key causes in the development and progression of multiple myeloma (MM). In this study, global microRNA (miRNA) expression profiling were performed for 27 MM (19 specimens and 8 cell lines) and 3 normal controls by microarray. miRNA-targets were identified by integrating the miRNA expression profiles with mRNA expression profiles of the matched samples (unpublished data). Two miRNAs were selected for verification by RT-qPCR (miR-150-5p and miR-4430). A total of 1791 and 8 miRNAs were over-expressed and under-expressed, respectively in MM compared to the controls (fold change ≥2.0; p < 0.05). The miRNA-mRNA integrative analysis revealed inverse correlation between 5 putative target genes (RAD54L, CCNA2, CYSLTR2, RASGRF2 and HKDC1) and 15 miRNAs (p < 0.05). Most of the differentially expressed miRNAs are involved in survival, proliferation, migration, invasion and drug resistance in MM. Some have never been described in association with MM (miR-33a, miR-9 and miR-211). Interestingly, our results revealed 2 miRNAs, which are closely related to B cell differentiation (miR-150 and miR-125b). For the first time, we suggest that miR-150 might be potential negative regulator for two critical cell cycle control genes, RAD54L and CCNA2, whereas miR-125b potentially target RAS and CysLT signaling proteins, namely RASGRF2 and CYSLTR2, respectively. This study has enhanced our understanding on the pathobiology of MM and opens up new avenues for future research in myelomagenesis.

Highlights

Multiple myeloma (MM) is a malignancy of B lymphocytes, characterised by clonal expansion of malignant plasma cells in the bone marrow and over-production of intact monoclonal immunoglobulin of a single type (M-protein) (Eslick and Talaulikar 2013)
We suggest that miR150 might be potential negative regulator for two critical cell cycle control genes, RAD54L and CCNA2, whereas miR-125b potentially target RAS and CysLT signaling proteins, namely RASGRF2 and CYSLTR2, respectively
MiRNAs are negative regulators for gene expression, the expression of a target mRNA is expected to be anti-correlated with miRNA expression (Lionetti et al 2009)

Summary

Introduction

Multiple myeloma (MM) is a malignancy of B lymphocytes, characterised by clonal expansion of malignant plasma cells in the bone marrow and over-production of intact monoclonal immunoglobulin of a single type (M-protein) (Eslick and Talaulikar 2013). In. Genes Genom (2017) 39:533–540 cancer, miRNAs function as regulatory molecules that can act as either an oncomiR or a tumour suppressor (Bi and Chng 2014). Genes Genom (2017) 39:533–540 cancer, miRNAs function as regulatory molecules that can act as either an oncomiR or a tumour suppressor (Bi and Chng 2014) Their abnormal expression causes tumour formation by disrupting mechanisms that controlling apoptosis, angiogenesis, cell proliferation, invasion, and other critical signaling pathways (Dimopoulos et al 2014)

Methods

Results

Discussion

Conclusion